{
    "2020-11-10": [
        [
            {
                "time": "",
                "original_text": "广东上市药企前三季度近九成实现盈利 业绩分化下医疗器械板块独领风骚",
                "features": {
                    "keywords": [
                        "广东",
                        "上市药企",
                        "盈利",
                        "医疗器械",
                        "板块"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因现4笔大宗交易 共成交16,447.20万元",
                "features": {
                    "keywords": [
                        "华大基因",
                        "大宗交易",
                        "成交金额"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫苗研发迎重大进展 关注这些疫苗概念超跌股",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "研发进展",
                        "疫苗概念",
                        "超跌股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "华大基因：新冠检测试剂需求 有望常态化",
                "features": {
                    "keywords": [
                        "华大基因",
                        "新冠检测",
                        "试剂需求",
                        "常态化"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}